Test Price
2,800 AEDโ Home Collection Available
RYR1 Gene Analysis (Minicore Myopathy with External Ophthalmoplegia) โ Genetic Test in UAE
Executive Summary & Core Metrics
Executive Summary: Comprehensive single-gene NGS analysis of the RYR1 gene delivering 99.9% analytic sensitivity for diagnosing minicore myopathy with external ophthalmoplegia. The test includes ISO-certified cold-chain home collection, post-result telephonic genetic counselling by a DHA-licensed Consultant Medical Geneticist, and direct insurance verification via WhatsApp +971 54 548 8731 under UAE PDPL compliance.
โ 99.9% Diagnostic Sensitivity
ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139)
๐ VIP Mobile Phlebotomy & Cold-Chain Home Collection
Available daily from 8 AM to 11 PM with temperature-controlled specimen transport
๐ Post-Test Clinical Guidance
Telephonic genetic counselling & result interpretation with DHA-licensed Consultant Medical Geneticist
๐ฐ Direct Insurance Verification
WhatsApp +971 54 548 8731 for instant pre-approval under UAE PDPL compliance
Test Overview & Methodology
Our comprehensive NGS test analyses the entire RYR1 gene to detect pathogenic variants causing minicore myopathy with external ophthalmoplegia. This single-gene sequencing approach delivers definitive molecular diagnosis in 3โ4 weeks, while the standard alternative โ a broad neuromuscular panel โ often lacks targeted depth and may extend turnaround to 6โ8 weeks. The test requires only a simple blood draw, extracted DNA, or an FTA card sample, ensuring minimal discomfort and maximum clinical utility.
| Feature | Our RYR1 Single-Gene NGS Test | Closest Alternative (Broad Neuromuscular Panel) |
|---|---|---|
| Precision | 100% coverage of coding regions ยฑ10 bp; detects SNVs, indels, CNVs | Variable depth; may miss deep intronic or exon-level variants |
| Methodology | NGS + Transcriptome/RNA Sequencing (if needed) | NGS only; no RNA analysis |
| Speed | 3โ4 Weeks | 6โ8 Weeks |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Geneticist, I confirm that RYR1 gene sequencing provides definitive molecular confirmation for minicore myopathy with external ophthalmoplegia when clinical suspicion is high. A detected pathogenic variant must be correlated with the patientโs neuromuscular presentation, family pedigree, and ancillary studies such as muscle biopsy or electromyography. This test enables accurate prognosis, guides family cascade screening, and supports reproductive counselling. Patients should continue all prescribed treatments and discuss any management changes with their referring neurologist.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ ๏ธ Medication Safety Advisory
Do not discontinue prescribed medication without consulting your doctor.
No drugs, supplements, or herbal preparations need to be stopped prior to this genetic test. Continue all current regimens unless explicitly instructed by your physician.
๐จ Exclusion Criteria & Emergency Red Flags
- Test is not indicated for acute neuromuscular crisis management; if the patient experiences sudden respiratory distress, severe muscle weakness, or swallowing difficulties, proceed to the nearest ER immediately.
- Not suitable as a stand-alone screening for asymptomatic minors unless conducted within a structured genetic counselling context with appropriate consent.
- Refuse sample collection if the patient is febrile or shows signs of active infection; reschedule after recovery.
Patient FAQ & Clinical Guidance
1. What exactly does the RYR1 gene test detect, and how reliable is the result?
The RYR1 NGS test identifies pathogenic mutations in the ryanodine receptor gene with 99.9% analytic sensitivity, detecting even rare intronic variants that may cause minicore myopathy. It sequences the entire coding region and flanking splice sites, with RNA confirmation if needed, ensuring a clinically reliable result. Your physician will interpret the mutation in the context of your symptoms and family history.
2. Can I use my health insurance for this test, and what is the procedure?
Yes, we can directly bill most UAE insurers if you provide the policy number via WhatsApp +971 54 548 8731 and receive instant verification under strict PDPL data privacy protocols. After approval, our mobile phlebotomist will visit your location (hotel, home, or office) within hours. The total cost of 2800 AED includes sample collection, genetic counselling, and a comprehensive PDF report.
3. How long will it take to receive the results, and who will explain them?
Your final report, signed by a molecular geneticist, is delivered in 3 to 4 weeks, followed by a telephonic consultation with a Consultant Medical Geneticist for interpretation. We guarantee a plain-language summary with actionable clinical recommendations. Urgent partial results for known familial variants can be expedited upon request.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: All personal data and genetic information are processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143 and is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | RYR1 Gene Analysis (Minicore Myopathy with External Ophthalmoplegia) โ Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Sample |
| Methodology Used | Next-Generation Sequencing (NGS) + Transcriptome/RNA Sequencing (if needed) |
| ICD-10-CM Code | G71.2 (Congenital myopathy), Z15.89 (Genetic susceptibility to other disease), Z14.8 (Genetic carrier confirmed) |
| LOINC Code | 76720-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians